Leah Flatman: Patterns of Use and Discontinuation for TNF Inhibitors in Pregnant Women
Leah Flatman, Postdoctoral Fellow at Centre de recherche Azrieli du CHU Sainte-Justine, shared a post by The Journal of Rheumatology on LinkedIn:
“I am very grateful to The Journal of Rheumatology for publishing our recent study on TNF inhibitor use during pregnancy: Patterns of Use and Discontinuation for Tumor Necrosis Factor Inhibitors in Pregnant Women: Insights From a Real-World Sample.
I am also grateful to Laura Andreoli, Mette Julsgaard, and Karen Schreiber for their thoughtful commentary. Together, our articles highlight a key reality in pregnancy research: it has taken over a decade for TNF inhibitors to be used confidently in pregnancy, underscoring the need to generate safety data earlier in drug development.
We fully agree that better-informed decisions start with stronger evidence early on. Integrating pregnancy data into clinical development could make a real difference for women with chronic diseases who are planning a family.
It’s encouraging to see regulatory frameworks evolving, and collaborations between researchers, clinicians, and regulators will be essential to ensuring safe and effective treatments for mothers and babie.”
Quoting The Journal of Rheumatology’s post:
“Research Article
Patterns of Use and Discontinuation for Tumor Necrosis Factor Inhibitors in Pregnant Women: Insights From a Real-World Sample.”
Title: Patterns of Use and Discontinuation for Tumor Necrosis Factor Inhibitors in Pregnant Women: Insights From a Real-World Sample
Authors: Leah K. Flatman, Sasha Bernatsky, Anick Bérard, Évelyne Vinet
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic